MedPath

The effects of Goreisan on pain perception in Glossodynia associate with dry mouth

Not Applicable
Conditions
Glossodynia
Registration Number
JPRN-UMIN000035965
Lead Sponsor
agasaki University
Brief Summary

The administration of Goreisan for two weeks lead to significant reduction of pain perception based on the evaluation of Self-filled pain scale (VAS) and tongue perception test (QST). There is correlation between barometric pressure and self-filled VAS scale. This fact might indicate that Goreisan would be the alternative treatment for glossodynia patients. Goreisan would be a successful alternative treatment modality for glossodynia patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
14
Inclusion Criteria

Not provided

Exclusion Criteria

patients medicated with other Kampo drug patients with hypertension over diastolic pressure over 120mmHg severe liver and /or renal disease allergy for drug pregnant women patients attending other clinical study within 4 months patients should avoided based on researcher's evaluation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
pain evaluated by VAS
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath